Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Skin Therapy Letter
|
September 1, 2007
Cutaneous reactions to anticancer agents targeting the epidermal growth factor receptor: a dermatology-oncology perspective
M E Lacouture, B L Melosky
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2011
The effect of cytotoxic chemotherapy on the risk of high-grade acneiform rash to cetuximab in cancer patients: a meta-analysis
Y Balagula, S Wu, X Su, et al.
Clinical and Experimental Dermatology
|
April 19, 2020
The microbial flora of clinically infected cutaneous metastases: a retrospective study
C A Virgen, C A Barker, M E Lacouture
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 14, 2008
Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib
M E Lacouture, L M Reilly, P Gerami, et al.
Clinical and Experimental Dermatology
|
May 27, 2015
Incidence and risk of hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor: a meta-analysis
V R Belum, C Serna-Tamayo, S Wu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2015
Regorafenib-associated hand-foot skin reaction: practical advice on diagnosis, prevention, and management
B McLellan, F Ciardiello, M E Lacouture, et al.
Clinical and Experimental Dermatology
|
January 25, 2005
Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody
M E Lacouture, J M Baron, A B Jani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 10, 2012
Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib
G Dranitsaris, M D Vincent, J Yu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 16, 2008
Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib
S E Rosenbaum, S Wu, M A Newman, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
June 13, 2017
Post-reconstruction dermatitis of the breast
A C Rosen, C Goh, M E Lacouture, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Skin Therapy Letter
|
September 1, 2007
Cutaneous reactions to anticancer agents targeting the epidermal growth factor receptor: a dermatology-oncology perspective
M E Lacouture, B L Melosky
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2011
The effect of cytotoxic chemotherapy on the risk of high-grade acneiform rash to cetuximab in cancer patients: a meta-analysis
Y Balagula, S Wu, X Su, et al.
Clinical and Experimental Dermatology
|
April 19, 2020
The microbial flora of clinically infected cutaneous metastases: a retrospective study
C A Virgen, C A Barker, M E Lacouture
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 14, 2008
Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib
M E Lacouture, L M Reilly, P Gerami, et al.
Clinical and Experimental Dermatology
|
May 27, 2015
Incidence and risk of hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor: a meta-analysis
V R Belum, C Serna-Tamayo, S Wu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2015
Regorafenib-associated hand-foot skin reaction: practical advice on diagnosis, prevention, and management
B McLellan, F Ciardiello, M E Lacouture, et al.
Clinical and Experimental Dermatology
|
January 25, 2005
Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody
M E Lacouture, J M Baron, A B Jani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 10, 2012
Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib
G Dranitsaris, M D Vincent, J Yu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 16, 2008
Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib
S E Rosenbaum, S Wu, M A Newman, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
June 13, 2017
Post-reconstruction dermatitis of the breast
A C Rosen, C Goh, M E Lacouture, et al.
Page
of 3